Pretreatment ADC Histogram Analysis as a Prognostic Imaging Biomarker for Patients with Recurrent Glioblastoma Treated with Bevacizumab: A Systematic Review and Meta-analysis.

Published in: AJNR. American journal of neuroradiology (2022)

for bevacizumab treatment was not confirmed.

Keyphrases